Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)Clodagh Towns, Huifang Shang, Dena Hernández et al.|npj Parkinson s Disease|2023Cited by 39
<scp>NeuroBooster</scp> Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsSara Bandrés‐Ciga, Dan Vitale, Faraz Faghri et al.|Movement Disorders|2024Cited by 38
NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsSara Bandrés‐Ciga, Dan Vitale, Faraz Faghri et al.|medRxiv|2023Cited by 23
Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scoresPaula Saffie Awad, Bianca A. Llamas, Spencer Grant et al.|npj Parkinson s Disease|2025Cited by 5
Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populationsFulya Akçimen, Ismail O. Ishola, Kimberly Paquette et al.|medRxiv|2025Cited by 4